Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of miR-345-3p in preparation of medicine for treating breast cancer

A technology of breast cancer and medicine, applied in the field of breast cancer treatment

Pending Publication Date: 2021-11-30
重庆医科大学国际体外诊断研究院
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, so far, there is no literature report on the role and molecular mechanism of miR-345-3p in breast cancer.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of miR-345-3p in preparation of medicine for treating breast cancer
  • Application of miR-345-3p in preparation of medicine for treating breast cancer
  • Application of miR-345-3p in preparation of medicine for treating breast cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] miR-345-3p is highly expressed in breast cancer tissues and breast cancer cells

[0057] In order to analyze the expression of miR-345-3p in breast cancer tissue and two types of breast cancer cells, this example collected breast cancer patients (from the Pathology Department of the First Affiliated Hospital of Chongqing Medical University) and paired In paracancerous tissues, the expression level of miR-345-3p in the tissue was detected by FISH experiment. The FISH experiment process was as follows: MicroRNA FISH probe and fluorescence in situ hybridization (FISH) kit (Shanghai Gemma) were used to detect miR-345-3p. 3p expression in human breast cancer tissue and paired normal breast tissue, paraffin sections were dewaxed with xylene and graded alcohol, digested with proteinase K and denatured at 78°C for 8 minutes, and then incubated with pre-denatured miR at 37°C -345-3p FISH probe was hybridized overnight; nuclei were stained with DAPI; photographed with a confocal ...

Embodiment 2

[0060] Study on the biological effect of knocking down miR-345-3p to inhibit the invasion, migration and proliferation of breast cancer cells.

[0061] As a negative control, negative control inhibitors were transfected in this example, and the effect of knocking down miR-345-3p on the proliferation, migration and invasion of breast cancer cells was detected by cck8, scratch test and tmaswell test.

[0062] cck8 experiment:

[0063] The Cell Counting Kit-8 (CCK8) (MCE) assay was used to determine the proliferative capacity of the cells. The miR-345-3p inhibitors were transfected in MDA-MB-231, and the negative control (NC) was used as the control. After 48 hours of treatment, the cell suspension was 5 × 10 3 Cells / well were seeded in 96-well plates. After 24 hours, 48 ​​hours and 72 hours respectively, cells were incubated with 10% Cell Counting Kit-8 (CCK8) for 1.5 hours at 37°C. Optical density (OD) values ​​at 450 nm were read in a digital spectrophotometer. Each exper...

Embodiment 3

[0070] This example verifies that knocking down miR-345-3p in breast cancer cells can down-regulate the PI3K / AKT signaling pathway by regulating PPP2CA.

[0071] In order to find out the mechanism of miR-345-3p in breast cancer, this example predicted the downstream target genes of miR-345-3p through the three online prediction websites Targetscan, miRDB and miRtarbase, and found that PPP2CA is miR-345- The possible target genes of 3p function, and the 3'UTR site of PPP2CA that miR-345-3p binds to is predicted, and the binding site is mutated ( Figure 6 , Figure 7 ).

[0072] has-miR-345-3p: 3'-GAGGUCUGGGGAGC AAGUCCC G-5' (SEQ ID No. 1);

[0073] PPP2CA3'UTR wildtype: 5'-UUGUUCUUUUUAUU UUCAGGG A-3' (SEQ ID No. 2);

[0074] PPP2CA3'UTR mutant: 5'-UUGUUCUUUUUAUUGGACUUUA-3' (SEQ ID No. 3).

[0075] Next, use the dual-luciferase reporter system to detect whether the target site is functional. The dual-luciferase reporter experiment process is as follows: use Lipofectamin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of breast cancer treatment, and particularly discloses application of miR-345-3p in preparation of a medicine for treating breast cancer. High expression of the miR-345-3p in human breast cancer tissues and breast cancer cell strains is revealed for the first time, and it is found that inhibition of expression of the miR-345-3p in breast cancer cells can effectively down-regulate a PI3K / AKT signal channel by promoting expression of PPP2CA, so that the miR-345-3p can be used as a new therapeutic target for breast cancer, and a new technical thought is provided for further researching the pathogenesis of the breast cancer and the function of the miR-345-3p gene.

Description

technical field [0001] The invention relates to the technical field of breast cancer treatment, in particular to the use of miR-345-3p in the preparation of breast cancer treatment drugs. Background technique [0002] Breast cancer is one of the most common malignant tumors in women, and its morbidity and mortality rank first among female malignant tumors. Distant metastasis of highly invasive breast cancer cells is the main cause of death in these women, but the specific pathogenesis of breast cancer remains unclear. Despite the continuous advancement of diagnosis and treatment techniques, recurrence, metastasis, and the development of chemotherapy resistance are inevitable in most cases, and the clinical outcomes of breast cancer patients are still unsatisfactory. Therefore, it is particularly important to explore some promising diagnostic and prognostic indicators for breast cancer, and more importantly, it can help optimize some specific diagnostic and treatment methods...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K45/00A61P35/00C12Q1/6886
CPCA61K45/00A61P35/00C12Q1/6886C12Q2600/136C12Q2600/158C12Q2600/178
Inventor 陈婷梅曾倩
Owner 重庆医科大学国际体外诊断研究院